Cutting edge:: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation

被引:116
作者
Carr, William H. [1 ]
Rosen, David B.
Arase, Hisashi
Nixon, Douglas F.
Michaelsson, Jakob
Lanier, Lewis L.
机构
[1] Univ Calif San Francisco, Dept Microbiol & Immunol, Canc Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA
[3] Osaka Univ, Dept Immunochem, Res Inst Microbial Dis, Osaka, Japan
[4] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA
[5] Karolinska Inst, Karolinska Univ Hosp, Ctr Infect Med, Dept Med, Stockholm, Sweden
关键词
D O I
10.4049/jimmunol.178.2.647
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The killer cell Ig-like receptor (M) gene, KIR3DS1, has been implicated in slowing disease progression in HIV infection; however, little is known about its expression, function, or ligand specificity. Using retrovirally transduced NKL cells and peripheral blood NK cells from KIR3DS1-positive donors we assessed expression of this gene by flow cytometry and its function by in vitro assays measuring KIR3DS1-induced cell-mediated cytotoxicity and cytokine production. In the present study, we demonstrate that KIR3DS1 is expressed on peripheral blood NK cells and triggers both cytotoxicity and IFN-gamma production. Using A cotransfection and coimmunoprecipitation, we found 4 that KIR3DS1 associates with the ITAM-bearing adaptor, DAP12. Soluble KIR3DS1-Ig fusion proteins did not bind to EBV-transformed B lymphoid cell lines transfected with HLA-Bw4 80I or 80T allotypes, suggesting that if KIR3DS1 does recognize HLA-Bw4 ligands, this may be peptide dependent.
引用
收藏
页码:647 / 651
页数:5
相关论文
共 25 条
  • [1] Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors
    Arase, H
    Mocarski, ES
    Campbell, AE
    Hill, AB
    Lanier, LL
    [J]. SCIENCE, 2002, 296 (5571) : 1323 - 1326
  • [2] AMINO-ACID SUBSTITUTIONS CAN INFLUENCE THE NATURAL-KILLER (NK)-MEDIATED RECOGNITION OF HLA-C MOLECULES - POLE OF SERINE-77 AND LYSINE-80 IN THE TARGET-CELL PROTECTION FROM LYSIS MEDIATED BY GROUP-2 OR GROUP-1 NK CLONES
    BIASSONI, R
    FALCO, M
    CAMBIAGGI, A
    COSTA, P
    VERDIANI, S
    PENDE, D
    CONTE, R
    DIDONATO, C
    PARHAM, P
    MORETTA, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) : 605 - 609
  • [3] Campbell KS, 1998, EUR J IMMUNOL, V28, P599, DOI 10.1002/(SICI)1521-4141(199802)28:02<599::AID-IMMU599>3.0.CO
  • [4] 2-F
  • [5] KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand
    Carr, WH
    Pando, MJ
    Parham, P
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (08) : 5222 - 5229
  • [6] Alternatively spliced forms of human killer inhibitory receptors
    Dohring, C
    Samaridis, J
    Colonna, M
    [J]. IMMUNOGENETICS, 1996, 44 (03) : 227 - 230
  • [7] NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation
    Gilfillan, S
    Ho, EL
    Cella, M
    Yokoyama, WM
    Colonna, M
    [J]. NATURE IMMUNOLOGY, 2002, 3 (12) : 1150 - 1155
  • [8] THE BW4 PUBLIC EPITOPE OF HLA-B MOLECULES CONFERS REACTIVITY WITH NATURAL-KILLER-CELL CLONES THAT EXPRESS NKB1, A PUTATIVE HLA RECEPTOR
    GUMPERZ, JE
    LITWIN, V
    PHILLIPS, JH
    LANIER, LL
    PARHAM, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) : 1133 - 1144
  • [9] Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific
    Hansasuta, P
    Dong, T
    Thananchai, H
    Weekes, M
    Willberg, C
    Aldemir, H
    Rowland-Jones, S
    Braud, VM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (06) : 1673 - 1679
  • [10] Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
    Imai, C
    Iwamoto, S
    Campana, D
    [J]. BLOOD, 2005, 106 (01) : 376 - 383